PE's reliable sampling

Published: 3-Mar-2001

New Series 200 Autosampler from PerkinElmer


Flexibility, reliability and ease of use are the key features of the Series 200 Autosampler, new from PerkinElmer.

For high throughput, high-speed sampling, the Series 200 Autosampler can hold 225 samples, with up to three injections/min. Users can obtain maximum precision from microbore to semi-prep injections using fixed or variable-fill modes. Pre-column dilution and derivisation are standard.

  • Companies:
  • PerkinElmer
See more

You may also like

Research & Development

Revvity expands partnership with Scitara to advance digital lab

Read more
Since April 2022, Scitara and Revvity Signals Software have worked together to help R&D teams create fully connected laboratories via Scitara’s Digital Lab Exchange DLX

Trending Articles

  1. LUNA 3: Rilzabrutinib Phase III immune thrombocytopenia trial meets primary endpoint Rilzabrutinib met both the primary endpoint of durable platelet response and various secondary endpoints in patients who were refractory to prior therapy
  2. Fasenra for EGPA: addressing unmet needs Benralizumab could offer patients with EGPA more treatment options, while reducing dependency on oral corticosteroids
  3. Catalent and AstraZeneca to expand support for COVID-19 vaccine AZD1222 Catalent will prepare the Harmans facility, close to Baltimore-Washington International (BWI) airport, to enable multiple production trains to run in parallel to produce the vaccine candidate drug substance commencing late in the third quarter of 2020
  4. Chemistry, manufacturing and control (CMC) as key drivers for drug discovery success Embracing collaborative strategies not only accelerates drug development programmes but also fosters science-based milestone decisions, mitigates risks and prepares for successful market entry from the early stages of development, reports Frederick Duynslaeger, Senior CMC Writer at Ardena
  5. Bristol Myers Squibb and Cellares partner to expand CAR-T manufacturing capabilities Cellares will optimise and automate select Bristol Myers Squibb CAR-T cell therapies onto its high-throughput manufacturing program, the Cell Shuttle

Upcoming event

Cleanroom Conference UK

22–23 May 2024 | Exhibition | Birmingham, UK See all

You may also like

Research & Development

Revvity expands partnership with Scitara to advance digital lab

Since April 2022, Scitara and Revvity Signals Software have worked together to help R&D teams create fully connected laboratories via Scitara’s Digital Lab Exchange DLX
Manufacturing

Revvity establishes centre for "genomic insight" in Cambridge, UK

From its Scientific Centre of Excellence, Revvity delivers cell line engineering and screening services to improve the outcomes of drug development through enhanced target selection
Research & Development

PerkinElmer unveils cell analysis for gene therapy research

The Cellaca PLX Image Cytometer “redefines workflows” and addresses multiple critical quality attributes
Research & Development

Tackling drug resistance in immuno-oncology: the role of combinational therapy

The application of immunotherapy for cancer treatment has burgeoned during the past decade, transforming the way we manage certain types of cancer. However, many patients do not respond to immunotherapy or they develop resistance to the treatment
Manufacturing

Carterra and PerkinElmer sign Asia-Pacific distribution agreement

The distributor will supply Carterra’s antibody screening and characterisation solutions in the Asia-Pacific and Oceania regions
Ingredients

PerkinElmer completes $5.25bn acquisition of antibody specialist

BioLegend has been acquired by PerkinElmer in the largest acquisition in the company's history
Regulatory

Lab Innovations 2018 confirmed as a major hit with visitors, exhibitors and speakers

More visitors than ever before and organisers announce dates for next year’s show: 30-31st October 2019
Subscribe now